Page 37 - NIS English, December 16-31,2022
P. 37
2022: Year of Willpower Cover Story
The pandemic has brought the A BIG PUSH FROM THE
pharmaceutical sector to centre
stage. Be it lifestyle or drugs, PHARMA INDUSTRY TO
medical technology or vaccines,
every aspect of health care has AATMANIRBHAR BHARAT
attracted the attention of the
whole world. In this context, the During the Covid period, when there was
pharmaceutical industry has also a shortage of life-saving medicines in the
risen to the challenge.
Narendra Modi, Prime Minister world, India became a global pharmacy
and supplied medicines to more than 150
countries. As the largest manufacturer
of vaccines, India has given more than
25 crore doses to 100 countries. With
the Atmanirbhar Bharat Abhiyan, India's
pharmacy is now becoming the world's
pharmacy...
India's pharmaceutical industry is the
world's third-largest in terms of volume.
India accounts for around 20 percent of
global exports of generic drugs. Also,
more than 500 pharmaceutical ingredients
are being manufactured in India.
CeraVac: It is India's first indigenously
developed vaccine for the prevention of
cervical cancer.
India's drugs & pharmaceutical exports
increased by 103 percent from FY
2013-14 to FY 2021-22, rising from Rs
90,415 crore to Rs 1,83,422 crore. The
pharmaceutical sector's exports during
the fiscal year 2021-22 were the best ever.
Several initiatives, including the PLI
scheme, have benefited the four medical
device parks in Tamil Nadu, Madhya
Pradesh, Himachal Pradesh, and Uttar
Pradesh, as well as the pharma sector.
Also, the Medical Device Policy is in the
final stages of approval and includes input
In the last eight years, the government from various stakeholders.
has taken various initiatives to further the The Department of Pharmaceuticals under
development of this sector. The Indian Ministry of Chemicals and Fertilizers
healthcare industry has been growing at a has issued guidelines for the scheme
rapid pace since 2016 and was estimated to "Strengthening the Pharmaceutical
reach $380 billion by 2022. Industry," with a total financial outlay of
Rs 500 crore for the period FY 21–22 to
FY 25–26.
New India Samachar December 16-31, 2022 35
